In summary, CXCR2 expressing ovarian cancer cells potentiated NF-κB activation via EGFR-transactivated Akt signaling to induce CXCL1/2 secretion as an autocrine or paracrine growth factor. This evidence concerns the gene EGFR and ovarian cancer.